Financial results - AMA ONCOLOGY S.R.L.

Financial Summary - Ama Oncology S.r.l.
Unique identification code: 39953371
Registration number: J2018002100165
Nace: 8610
Sales - Ron
96.127
Net Profit - Ron
64.215
Employees
1
Open Account
Company Ama Oncology S.r.l. with Fiscal Code 39953371 recorded a turnover of 2024 of 96.127, with a net profit of 64.215 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă spitalicească having the NACE code 8610.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Ama Oncology S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 3.256 6.157 11.400 45.577 97.209 96.127
Total Income - EUR - - - - 3.256 6.157 11.405 45.582 97.233 98.470
Total Expenses - EUR - - - - 562 83 960 771 10.965 31.301
Gross Profit/Loss - EUR - - - - 2.694 6.074 10.445 44.812 86.268 67.169
Net Profit/Loss - EUR - - - - 2.596 5.899 10.103 43.676 85.296 64.215
Employees - - - - 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -0.6%, from 97.209 euro in the year 2023, to 96.127 euro in 2024. The Net Profit decreased by -20.604 euro, from 85.296 euro in 2023, to 64.215 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Ama Oncology S.r.l.

Rating financiar

Financial Rating -
AMA ONCOLOGY S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Ama Oncology S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ama Oncology S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Ama Oncology S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ama Oncology S.r.l. - CUI 39953371

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 0 0 760 2.465 40.630 55.646
Current Assets - - - - 2.872 6.667 10.506 52.830 80.780 32.450
Inventories - - - - 6 6 0 0 0 567
Receivables - - - - 464 552 1.558 36.564 34.674 12.431
Cash - - - - 2.402 6.109 8.949 16.266 46.106 19.451
Shareholders Funds - - - - 2.638 6.419 10.315 43.753 96.569 84.105
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 235 247 951 11.542 25.011 4.316
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8610 - 8610"
CAEN Financial Year 8610
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 32.450 euro in 2024 which includes Inventories of 567 euro, Receivables of 12.431 euro and cash availability of 19.451 euro.
The company's Equity was valued at 84.105 euro, while total Liabilities amounted to 4.316 euro. Equity decreased by -11.925 euro, from 96.569 euro in 2023, to 84.105 in 2024.

Risk Reports Prices

Reviews - Ama Oncology S.r.l.

Comments - Ama Oncology S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.